Structure Therapeutics Inc (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Structure Therapeutics Inc - ADR: Is Infosys Ltd. worth buying?
Item: Structure Therapeutics Inc - ADR
Rating: 1.24750
Author: Trendlyne DVM scores

about

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both struc...

39.84 1.76 (4.62%)

58.02% Fall from 52W High

822.7K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.0 / 100

Technically Neutral

40.9 / 100

No estimates available

Structure Therapeutics Inc (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Structure Therapeutics Inc (ADR) Live Stock Price Today, Share Analysis and Chart

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both struc...

58.02% Fall from 52W High

SWOT Analysis

Structure Therapeutics Inc (ADR) Live Price Chart